Pulmonx (LUNG) Shares Outstanding (Diluted Average) (2020 - 2025)

Pulmonx (LUNG) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $40.9 million in Q3 2025.

• Quarterly Shares Outstanding (Diluted Average) rose 5.09% year-over-year to $40.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $40.9 million (up 5.09% YoY) and the FY2024 annual result came in at $39.1 million, up 2.99% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $40.9 million in Q3 2025 per LUNG's latest filing, from $40.4 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $40.9 million in Q3 2025 and bottomed at $35.4 million in Q1 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $37.8 million (2023), against an average of $37.9 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Diluted Average) soared 1744.99%; it then increased 1.51% in 2022.
• Tracing LUNG's Shares Outstanding (Diluted Average) over 5 years: stood at $36.1 million in 2021, then increased by 2.68% to $37.1 million in 2022, then grew by 2.37% to $38.0 million in 2023, then increased by 2.99% to $39.1 million in 2024, then climbed by 4.67% to $40.9 million in 2025.
• Per Business Quant, the three latest LUNG Shares Outstanding (Diluted Average) figures stand at $40.9 million (Q3 2025), $40.4 million (Q2 2025), and $40.0 million (Q1 2025).

Peer Comparison